Get started
Award

81871985

Subfield: Hepatology
Field: Medicine
Funded outputs count: 30
Funder award ID: 81871985
OpenAlex ID: G3043040468
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy
2023 · Min Deng, Rongce Zhao, et al. · European journal of medical research · 4
PDF
Hepatic arterial infusion chemotherapy versus transarterial chemoembolization, potential conversion therapies for single huge hepatocellular carcinoma: a retrospective comparison study
2023 · Min Deng, Hao Cai, et al. · International Journal of Surgery · 34
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study
2022 · Shao-Hua Li, Jie Mei, et al. · Journal of Clinical Oncology · 189
PDF
A preliminary study on drug switching strategy for second-line therapy after combination treatment of tyrosine kinase inhibitors and immune checkpoint inhibitors for unresectable hepatocellular carcinoma
2022 · Renguo Guan, Chengyou Yu, et al. · Frontiers in Pharmacology · 1
PDF
Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation
2022 · Renguo Guan, Jingwen Zou, et al. · BMC Cancer · 6
PDF
Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
2022 · Zhen Zhang, Zi-Xian Wang, et al. · Genome Medicine · 290
PDF
Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma
2022 · Shaohua Li, Min Deng, et al. · Journal of Oncology · 11
PDF
Real-world outcomes of patients with advanced intrahepatic cholangiocarcinoma treated with programmed cell death protein-1-targeted immunotherapy
2022 · Min Deng, Shaohua Li, et al. · Annals of Medicine · 21
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
2022 · Min Deng, Shiquan Sun, et al. · Molecular Medicine · 89
PDF
Long noncoding RNA TINCR facilitates hepatocellular carcinoma progression and dampens chemosensitivity to oxaliplatin by regulating the miR-195-3p/ST6GAL1/NF-κB pathway
2022 · Jie Mei, Wenping Lin, et al. · Journal of Experimental & Clinical Cancer Research · 35
PDF
Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma
2021 · Min Deng, Jia-Bao Lin, et al. · BMC Cancer · 7
PDF
Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma
2021 · Wen-Ping Lin, Kai-Li Xing, et al. · JAMA Network Open · 70
PDF
Prognostic nomogram predicting survival of patients with unresectable hepatocellular carcinoma after hepatic arterial infusion chemotherapy
2021 · Jie Mei, Wen-Ping Lin, et al. · European Journal of Radiology · 12
Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
2021 · Jie Mei, Xu-Qi Sun, et al. · Journal of Inflammation Research · 51
PDF
Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients
2021 · Min Deng, Shao-Hua Li, et al. · Cancer Cell International · 53
PDF
Cezanne enhances epithelial mesenchymal transition and prevents anthracycline-induced apoptosis via AKT/mTOR signaling in hepatocellular carcinoma
2021 · Xiao-Ping Zhong, Jiahong Wang, et al. · Research Square
PDF
The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early‐stage hepatocellular carcinoma
2021 · Zhi‐Yuan Chen, Zhi‐Xing Guo, et al. · Cancer Medicine · 22
Transarterial infusion chemotherapy with FOLFOX for advanced hepatocellular carcinoma: a multi-center propensity score matched analysis of real-world practice
2021 · Shaohua Li, Jie Mei, et al. · HepatoBiliary Surgery and Nutrition · 26
PDF
Immune‐related adverse events predict responses to PD ‐1 blockade immunotherapy in hepatocellular carcinoma
2021 · Lianghe Lu, Kaili Xing, et al. · International Journal of Cancer · 28
The Predictive Value of Vessels Encapsulating Tumor Clusters in Treatment Optimization for Recurrent Early-stage Hepatocellular Carcinoma
2021 · Zhi-Yuan Chen, Zhi-Xing Guo, et al. · Research Square
PDF
The lymphocyte-C-reactive protein ratio as the optimal inflammation-based score in patients with hepatocellular carcinoma underwent TACE
2021 · Liang-He Lu, Wei Wei, et al. · Aging · 32
PDF
EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
2021 · Zhen Zhang, Hao-Xiang Wu, et al. · BMC Medicine · 56
PDF
Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA
2021 · Huiyan Luo, Wei Wei, et al. · Trends in Molecular Medicine · 340
The Predictive Value of Vessels Encapsulating Tumor Clusters in Treatment Optimization for Recurrent Early-Stage Hepatocellular Carcinoma
2020 · Zhi-Yuan Chen, Zhi-Xing Guo, et al. · Research Square · 1
PDF
Lymphocyte‐C‐reactive protein ratio as a novel prognostic index in intrahepatic cholangiocarcinoma: A multicentre cohort study
2020 · Liang‐He Lu, Chong Zhong, et al. · Liver International · 60